Metallodrugs were classically screened against skin cancer (either in vitro or in vivo) at the
peak of the development of platinum anticancer agents. New systematic studies appeared in …

Chiral sulfoxide is considered to be an ideal candidate ligand for transition-metal-catalyzed
asymmetric reactions due to its ease of synthesis, stability, and exceptional S-stereological …

We herein report the synthesis, characterization, and anticancer activity of a series of iridium
(III) and ruthenium (II) half-sandwich complexes of the type [(Cpx/arene) M (P^ O) Cl] PF6 …

The synthesis and characterization of chiral pincer-ruthenium complexes of the type
(R2NNN) RuCl2 (PPh3)(R= 3-methylbutyl and 3, 3-dimethylbutyl) is reported here. The …

Ruthenium complexes are attracting interest in cancer treatment due to their potent cytotoxic
activity. However, as their high toxicity may also affect healthy tissues, efficient and selective …

The (pentamethylcyclopentadienyl) chloridoiridium (III) complex bearing a κ P, κ S-bonded
Ph2PCH2CH2SPh ligand ([Ir (η5-C5Me5) Cl (Ph2P (CH2) 2SPh-κ P, κ S)] PF6,(1)] was …

In this work, new substituted benzimidazolium salts 2a–d having different groups on the side
chain have been synthesized and reacted with Ag2O to produce Ag (I) N-heterocyclic …

The rational design by the introduction of fluorine into a compound has achieved success in
the development of organic anticancer drugs. However, the fluorine effect in metal-based …

Herein we present the synthesis and characterization of a panel of structurally related
zwitterionic piano-stool rhodium (III) and ruthenium (II) complexes. The identities of these …

The rapid and modular synthesis of the aminophosphine core has been exploited as a tool
for rapid development of antitumoral metallodrug candidates. Starting with a series of …